• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤中的mycN/max蛋白复合物。简短综述。

The mycN/max protein complex in neuroblastoma. Short review.

作者信息

Wenzel A, Schwab M

机构信息

Department of Cytogenetics, German Cancer Research Center, Heidelberg, Germany.

出版信息

Eur J Cancer. 1995;31A(4):516-9. doi: 10.1016/0959-8049(95)00060-v.

DOI:10.1016/0959-8049(95)00060-v
PMID:7576956
Abstract

The oncogenic activation by amplification of the MYCN gene is frequently observed in human neuroblastomas and occasionally in other tumours with neuronal qualities. As a consequence of amplification, elevated levels of the mycN protein are expressed. mycN contains a C-terminal basic region (BR) that can bind to DNA, and a helix-loop-helix (HLH)-leucine zipper (Zip) domain, which is responsible for the physical interaction with another HLH-Zip protein, max. This principle structure is conserved among all members of the MYC gene family. The resulting dimers can bind to the DNA sequence CACGTG. The mycN protein, but not max, contains, near the N-terminus, a region conferring the ability to activate the transcription of genes. mycN/max heterodimers probably activate and max/max homodimers repress transcription of, as yet, unidentified target genes. In neuroblastoma cells, where mycN is deregulated, the balanced interaction of BR-HLH-Zip proteins is probably perturbed, and, therefore, genes controlled by mycN might be abnormally expressed and thereby alter normal cell growth with the consequence of tumorigenesis.

摘要

MYCN基因扩增导致的致癌激活在人类神经母细胞瘤中经常可见,偶尔也见于其他具有神经元特征的肿瘤。作为扩增的结果,mycN蛋白表达水平升高。mycN包含一个可与DNA结合的C端碱性区域(BR),以及一个螺旋-环-螺旋(HLH)-亮氨酸拉链(Zip)结构域,该结构域负责与另一个HLH-Zip蛋白max进行物理相互作用。这种基本结构在MYC基因家族的所有成员中都是保守的。形成的二聚体可与DNA序列CACGTG结合。mycN蛋白在N端附近含有一个赋予激活基因转录能力的区域,而max则没有。mycN/max异二聚体可能激活,而max/max同二聚体可能抑制尚未确定的靶基因的转录。在mycN失调的神经母细胞瘤细胞中,BR-HLH-Zip蛋白的平衡相互作用可能受到干扰,因此,受mycN控制的基因可能会异常表达,从而改变正常细胞生长,导致肿瘤发生。

相似文献

1
The mycN/max protein complex in neuroblastoma. Short review.神经母细胞瘤中的mycN/max蛋白复合物。简短综述。
Eur J Cancer. 1995;31A(4):516-9. doi: 10.1016/0959-8049(95)00060-v.
2
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.Max:一种螺旋-环-螺旋拉链蛋白,可与Myc形成序列特异性DNA结合复合物。
Science. 1991 Mar 8;251(4998):1211-7. doi: 10.1126/science.2006410.
3
Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.Myc与λ阻遏物-HLH结构域融合体相互作用特异性的分析。
J Mol Biol. 1995 May 5;248(3):541-50. doi: 10.1006/jmbi.1995.0241.
4
Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts.c-Myc螺旋-环-螺旋/亮氨酸拉链结构域在小鼠3T3-L1成纤维细胞中诱导细胞凋亡
J Biol Chem. 1995 Dec 1;270(48):28797-805. doi: 10.1074/jbc.270.48.28797.
5
Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.Mmip1:一种新型亮氨酸拉链蛋白,可逆转Mad家族成员对c-myc的抑制作用。
Oncogene. 1998 Mar 5;16(9):1149-59. doi: 10.1038/sj.onc.1201634.
6
Low molecular weight inhibitors of Myc-Max interaction and function.Myc-Max相互作用及功能的低分子量抑制剂
Oncogene. 2003 Sep 18;22(40):6151-9. doi: 10.1038/sj.onc.1206641.
7
Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.Myc和Max介导的转录激活:侧翼序列在体内将激活作用靶向至一部分CACGTG基序。
EMBO J. 1993 Dec 15;12(13):5075-82. doi: 10.1002/j.1460-2075.1993.tb06201.x.
8
A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.一种Max的显性负性突变体,可抑制Myc蛋白与序列特异性DNA的结合。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2739-43. doi: 10.1073/pnas.90.7.2739.
9
Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.在c-myc的内源性靶基因处对不同E盒结合蛋白的区分。
Genes Dev. 1996 Feb 15;10(4):447-60. doi: 10.1101/gad.10.4.447.
10
Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.人神经母细胞瘤细胞诱导分化过程中MYCN/Max和Mnt/Max的表达及DNA结合活性
J Cell Biochem. 2004 Aug 15;92(6):1282-95. doi: 10.1002/jcb.20121.

引用本文的文献

1
Antibody conjugates in neuroblastoma: a step forward in precision medicine.神经母细胞瘤中的抗体偶联物:精准医学的一大进步。
Front Oncol. 2025 Mar 10;15:1548524. doi: 10.3389/fonc.2025.1548524. eCollection 2025.
2
Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?靶向MYCN-MDM2通路进行癌症治疗:它们是否具有可药用性?
Genes Dis. 2023 Oct 27;12(2):101156. doi: 10.1016/j.gendis.2023.101156. eCollection 2025 Mar.
3
MYCN in human development and diseases.MYCN在人类发育与疾病中的作用。
Front Oncol. 2024 May 31;14:1417607. doi: 10.3389/fonc.2024.1417607. eCollection 2024.
4
A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.N-Myc 对细胞周期调控机制的研究综述。
Molecules. 2023 Jan 23;28(3):1141. doi: 10.3390/molecules28031141.
5
The Oncogene Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma.癌基因调节糖酵解和侵袭基因以增强人视网膜母细胞瘤的细胞活力和迁移能力。
Cancers (Basel). 2021 Oct 19;13(20):5248. doi: 10.3390/cancers13205248.
6
Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response.神经母细胞瘤的个性化医学:从静态基因型转向药物反应的动态模拟
J Pers Med. 2021 May 11;11(5):395. doi: 10.3390/jpm11050395.
7
Targeting in Pediatric and Adult Cancers.儿科和成人癌症中的靶向治疗
Front Oncol. 2021 Feb 8;10:623679. doi: 10.3389/fonc.2020.623679. eCollection 2020.
8
Molecular targeting therapies for neuroblastoma: Progress and challenges.神经母细胞瘤的分子靶向治疗:进展与挑战。
Med Res Rev. 2021 Mar;41(2):961-1021. doi: 10.1002/med.21750. Epub 2020 Nov 6.
9
Gangliosides and Neuroblastomas.神经节苷脂与神经母细胞瘤。
Int J Mol Sci. 2020 Jul 27;21(15):5313. doi: 10.3390/ijms21155313.
10
Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells.超越瓦伯格效应:N-Myc在癌细胞代谢重编程中的作用
Front Oncol. 2020 May 27;10:791. doi: 10.3389/fonc.2020.00791. eCollection 2020.